https://www.vistin.com https://www.vistin.com/about-us https://www.vistin.com/sustainability https://www.vistin.com/sustainability/healthy-environment https://www.vistin.com/products https://www.vistin.com/investors https://www.vistin.com/corporate-governance https://www.vistin.com/contact https://www.vistin.com/sustainability/people-in-focus https://www.vistin.com/sustainability/clean-operations https://www.vistin.com/privacy-policy https://www.vistin.com/announcements https://www.vistin.com/vacant-positions https://www.vistin.com/announcement/2024-annual-report-vistin-pharma-asa https://www.vistin.com/announcement/2025-annual-report-vistin-pharma-asa https://www.vistin.com/announcement/disclosure-of-large-shareholding-and-mandatory-notification-of-trade-in-vistin-pharma-asa https://www.vistin.com/announcement/disclosure-of-voting-rights-at-agm-in-vistin-pharma-asa https://www.vistin.com/announcement/disclosure-of-voting-rights-at-agm-in-vistin-pharma-asa-b0a36 https://www.vistin.com/announcement/disclosure-of-voting-rights-at-agm-in-vistin-pharma-asa-c8618 https://www.vistin.com/announcement/ex-dividend-nok-0-50-today https://www.vistin.com/announcement/ex-dividend-nok-0-50-today-a6ff3 https://www.vistin.com/announcement/ex-dividend-nok-0-75-today https://www.vistin.com/announcement/ex-dividend-nok-1-25-today https://www.vistin.com/announcement/management-in-vistin-pharma-asa-purchases-shares https://www.vistin.com/announcement/mandatory-notification-of-trade-in-vistin-pharma-asa https://www.vistin.com/announcement/new-interim-ceo https://www.vistin.com/announcement/notice-of-annual-general-meeting-in-vistin-pharma-asa https://www.vistin.com/announcement/responsibility-statement-for-first-half-year-of-2024 https://www.vistin.com/announcement/vistin-pharma-asa-annual-report-2023 https://www.vistin.com/announcement/vistin-pharma-asa-annual-report-for-2021 https://www.vistin.com/announcement/vistin-pharma-asa-annual-report-for-2022 https://www.vistin.com/announcement/vistin-pharma-asa-first-quarter-2022-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-first-quarter-2023-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-first-quarter-2024-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-first-quarter-2025-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-first-quarter-2026-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-fourth-quarter-and-preliminary-2022-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-fourth-quarter-and-preliminary-2023-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-fourth-quarter-and-preliminary-2024-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-fourth-quarter-and-preliminary-2025-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q1-2022-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q1-2023-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q1-2024-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q1-2025-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q1-2026-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q2-2022-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q2-2023-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q2-2024-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q2-2025-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q3-2022-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q3-2023-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q3-2024-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q3-2025-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q4-2021-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q4-2022-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q4-2023-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-invitation-to-q4-2024-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-key-information-relating-to-the-proposed-cash-dividend https://www.vistin.com/announcement/vistin-pharma-asa-key-information-relating-to-the-proposed-cash-dividend-b7891 https://www.vistin.com/announcement/vistin-pharma-asa-mandatory-notification-of-trade https://www.vistin.com/announcement/vistin-pharma-asa-mandatory-notification-of-trade-5d201 https://www.vistin.com/announcement/vistin-pharma-asa-mandatory-notification-of-trade-69e93 https://www.vistin.com/announcement/vistin-pharma-asa-mandatory-notification-of-trade-8 https://www.vistin.com/announcement/vistin-pharma-asa-mandatory-notification-of-trade-812b9 https://www.vistin.com/announcement/vistin-pharma-asa-mandatory-notification-of-trade-ba819 https://www.vistin.com/announcement/vistin-pharma-asa-mandatory-notification-of-trade-bd3bb https://www.vistin.com/announcement/vistin-pharma-asa-minutes-from-the-annual-general-meeting-2022 https://www.vistin.com/announcement/vistin-pharma-asa-minutes-from-the-annual-general-meeting-2023 https://www.vistin.com/announcement/vistin-pharma-asa-minutes-from-the-annual-general-meeting-2024 https://www.vistin.com/announcement/vistin-pharma-asa-minutes-from-the-annual-general-meeting-2025 https://www.vistin.com/announcement/vistin-pharma-asa-new-ceo-appointed https://www.vistin.com/announcement/vistin-pharma-asa-notice-of-annual-general-meeting https://www.vistin.com/announcement/vistin-pharma-asa-notice-of-annual-general-meeting-20-may-2026 https://www.vistin.com/announcement/vistin-pharma-asa-notice-of-annual-general-meeting-22-may-2025 https://www.vistin.com/announcement/vistin-pharma-asa-notice-of-annual-general-meeting-23-may-2024 https://www.vistin.com/announcement/vistin-pharma-asa-offer-to-buy-back-shares https://www.vistin.com/announcement/vistin-pharma-asa-ose-vistin-invitation-to-capital-markets-day-on-14th-of-june-at-the-metformin-manufacturing-plant-in-kragero https://www.vistin.com/announcement/vistin-pharma-asa-ose-vistin-presentation-from-today-s-capital-markets-day https://www.vistin.com/announcement/vistin-pharma-asa-results-of-offer-to-buy-back-shares https://www.vistin.com/announcement/vistin-pharma-asa-second-quarter-and-first-half-2022-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-second-quarter-and-first-half-2023-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-second-quarter-and-first-half-2024-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-second-quarter-and-ytd-2025-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-third-quarter-2023-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-third-quarter-and-ytd-2022-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-third-quarter-and-ytd-2024-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-third-quarter-and-ytd-2025-financial-results https://www.vistin.com/announcement/vistin-pharma-asa-vistn-acquires-minority-share-in-cf-pharma-hungary https://www.vistin.com/announcement/vistin-pharma-asa-vistn-acquires-minority-share-in-cf-pharma-hungary-175e3 https://www.vistin.com/announcement/vistin-pharma-asa-vistn-invitation-to-q4-2025-conference-call https://www.vistin.com/announcement/vistin-pharma-asa-vistn-key-information-relating-to-the-proposed-cash-dividend https://www.vistin.com/announcement/vistin-pharma-asa-vistn-mandatory-notification-of-trade-and-disclosure-of-large-shareholding https://www.vistin.com/announcement/vistin-pharma-asa-vistn-update-from-the-election-committee https://www.vistin.com/announcement/vistin-pharma-enters-into-a-long-term-renewable-energy-supply-agreement-with-statkraft